Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: April 2022
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of semaglutide 2.0 mg (Ozempic)'s approval, the use of novel glycemic control metrics, and a preview of ATTD 2022.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.